BAT-3306

N/A

Report date: 2026/02/14 20:00:22

Base Information

Drug NameBAT-3306

Drug Alias NameRecombinant Humanized Anti-PD-1 Monoclonal Antibody Solution帕博利珠单抗生物类似药（百奥泰生物）BAT3306BAT-3306

ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionAnti-PD-1

TargetsProgrammed cell death protein 1

Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySlovakiaThailandPhilippines +[7]

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesBio-Thera Solutions Ltd

China Registration ClassN/A

Develop Information

Active CompaniesBio-Thera Solutions Ltd

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A